MCID: RHM021
MIFTS: 51

Rheumatoid Arthritis, Systemic Juvenile

Categories: Genetic diseases, Bone diseases, Rare diseases, Respiratory diseases

Aliases & Classifications for Rheumatoid Arthritis, Systemic Juvenile

MalaCards integrated aliases for Rheumatoid Arthritis, Systemic Juvenile:

Name: Rheumatoid Arthritis, Systemic Juvenile 53 28 51 69
Rheumatoid Arthritis, Systemic Juvenile, Susceptibility to 53 13
Juvenile-Onset Still Disease 71 69
Systemic-Onset Juvenile Idiopathic Arthritis 55
Systemic Onset Juvenile Chronic Arthritis 69
Systemic Juvenile Rheumatoid Arthritis 53
Rheumatoid Arthritis Systemic Juvenile 71
Systemic Polyarthritis 55
Systemic-Onset Jia 55
Stills Disease 51
Still Disease 55
Rasj 71

Characteristics:

Orphanet epidemiological data:

55
systemic-onset juvenile idiopathic arthritis
Inheritance: Multigenic/multifactorial; Prevalence: 1-9/100000 (Europe); Age of onset: Childhood; Age of death: normal life expectancy;

Classifications:



External Ids:

OMIM 53 604302
Orphanet 55 ORPHA85414
UMLS via Orphanet 70 C0087031 C1384600
ICD10 via Orphanet 33 M08.2
MedGen 39 C1858558
MeSH 41 D001171

Summaries for Rheumatoid Arthritis, Systemic Juvenile

UniProtKB/Swiss-Prot : 71 Rheumatoid arthritis systemic juvenile: An inflammatory articular disorder with systemic-onset beginning before the age of 16. It represents a subgroup of juvenile arthritis associated with severe extraarticular features and occasionally fatal complications. During active phases of the disorder, patients display a typical daily spiking fever, an evanescent macular rash, lymphadenopathy, hepatosplenomegaly, serositis, myalgia and arthritis.

MalaCards based summary : Rheumatoid Arthritis, Systemic Juvenile, also known as rheumatoid arthritis, systemic juvenile, susceptibility to, is related to juvenile rheumatoid arthritis and adult-onset still's disease, and has symptoms including arthralgia, fever and abdominal pain. An important gene associated with Rheumatoid Arthritis, Systemic Juvenile is IL6 (Interleukin 6), and among its related pathways/superpathways are Innate Immune System and Cytokine Signaling in Immune system. The drugs Benzocaine and tannic acid have been mentioned in the context of this disorder. Affiliated tissues include skin and bone.

Wikipedia : 72 Systemic-onset juvenile idiopathic arthritis (also known as systemic juvenile idiopathic arthritis... more...

Description from OMIM: 604302

Related Diseases for Rheumatoid Arthritis, Systemic Juvenile

Diseases in the Rheumatoid Arthritis family:

Rheumatoid Arthritis, Systemic Juvenile Juvenile Rheumatoid Arthritis

Diseases related to Rheumatoid Arthritis, Systemic Juvenile via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 45)
# Related Disease Score Top Affiliating Genes
1 juvenile rheumatoid arthritis 32.3 HLA-DRB1 IL1R1 IL6
2 adult-onset still's disease 32.1 IL1R1 IL6 MIF
3 arthritis 29.1 HLA-DRB1 IL6 LACC1 MIF
4 rheumatoid arthritis 28.4 HLA-DRB1 IL1R1 IL6 LACC1 MIF
5 systemic onset juvenile idiopathic arthritis 12.5
6 macrophage activation syndrome 11.6
7 photokeratitis 10.2 IL6 MIF
8 cysticercosis 10.2 IL6 MIF
9 anca-associated vasculitis 10.2 HLA-DRB1 IL6
10 microscopic colitis 10.2 HLA-DRB1 IL6
11 central nervous system vasculitis 10.2 HLA-DRB1 IL6
12 hemorrhagic fever 10.2 HLA-DRB1 IL6
13 dengue shock syndrome 10.2 HLA-DRB1 IL6
14 rheumatoid vasculitis 10.2 HLA-DRB1 MIF
15 hemorrhagic fever with renal syndrome 10.1 HLA-DRB1 IL6
16 neuromyelitis optica 10.1 HLA-DRB1 IL6
17 idiopathic neutropenia 10.1 HLA-DRB1 IL6
18 mixed connective tissue disease 10.1 HLA-DRB1 IL6
19 cryopyrin-associated periodic syndrome 10.1 IL1R1 IL6
20 rheumatic heart disease 10.1 HLA-DRB1 IL6
21 rheumatoid factor-negative juvenile idiopathic arthritis 10.1 HLA-DRB1 IL2RB
22 echinococcosis 10.1 HLA-DRB1 IL6
23 ocular cicatricial pemphigoid 10.1 HLA-DRB1 MIF
24 post-transplant lymphoproliferative disease 10.1 IL1R1 IL6
25 dengue hemorrhagic fever 10.1 HLA-DRB1 IL6
26 radiculopathy 10.1 IL1R1 IL6
27 joint disorders 10.1 IL1R1 IL6
28 periventricular leukomalacia 10.1 IL1R1 IL6
29 leukomalacia 10.1 IL1R1 IL6
30 takayasu arteritis 10.1 HLA-DRB1 IL6
31 bone inflammation disease 10.0 HLA-DRB1 IL6
32 hypersensitivity reaction disease 10.0 HLA-DRB1 IL6
33 adult respiratory distress syndrome 10.0 IL1R1 IL6
34 chorioamnionitis 10.0 IL1R1 IL6
35 cholangitis 10.0 HLA-DRB1 IL6
36 autoinflammation, lipodystrophy, and dermatosis syndrome 10.0 IL1R1 IL6
37 graft-versus-host disease 10.0 HLA-DRB1 IL6
38 sarcoidosis 1 9.9 HLA-DRB1 MIF
39 oligoarticular juvenile idiopathic arthritis 9.8 HLA-DRB1 IL2RB MIF
40 rheumatic disease 9.8 HLA-DRB1 IL1R1
41 gastrointestinal system disease 9.7 IL6 MIF
42 temporal arteritis 9.6 HLA-DRB1 IL6 SERPINA3
43 inclusion body myositis 9.5 HLA-DRB1 SERPINA3
44 inflammatory bowel disease 9.1 HLA-DRB1 IL1R1 IL6 LACC1 MIF
45 malaria 9.0 HLA-DRB1 IL1R1 IL2RB IL6 MIF

Graphical network of the top 20 diseases related to Rheumatoid Arthritis, Systemic Juvenile:



Diseases related to Rheumatoid Arthritis, Systemic Juvenile

Symptoms & Phenotypes for Rheumatoid Arthritis, Systemic Juvenile

Clinical features from OMIM:

604302

Human phenotypes related to Rheumatoid Arthritis, Systemic Juvenile:

55 31 (show all 15)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 arthralgia 55 31 hallmark (90%) Very frequent (99-80%) HP:0002829
2 fever 55 31 hallmark (90%) Very frequent (99-80%) HP:0001945
3 abdominal pain 55 31 occasional (7.5%) Occasional (29-5%) HP:0002027
4 joint swelling 55 31 hallmark (90%) Very frequent (99-80%) HP:0001386
5 splenomegaly 55 31 occasional (7.5%) Occasional (29-5%) HP:0001744
6 hepatomegaly 55 31 occasional (7.5%) Occasional (29-5%) HP:0002240
7 autoimmunity 55 31 hallmark (90%) Very frequent (99-80%) HP:0002960
8 pericarditis 55 31 occasional (7.5%) Occasional (29-5%) HP:0001701
9 skin rash 55 31 hallmark (90%) Very frequent (99-80%) HP:0000988
10 elevated c-reactive protein level 55 31 hallmark (90%) Very frequent (99-80%) HP:0011227
11 lymphadenopathy 55 31 frequent (33%) Frequent (79-30%) HP:0002716
12 pleural effusion 55 31 occasional (7.5%) Occasional (29-5%) HP:0002202
13 elevated erythrocyte sedimentation rate 55 31 hallmark (90%) Very frequent (99-80%) HP:0003565
14 anterior uveitis 55 31 occasional (7.5%) Occasional (29-5%) HP:0012122
15 juvenile rheumatoid arthritis 55 31 hallmark (90%) Very frequent (99-80%) HP:0005681

Drugs & Therapeutics for Rheumatoid Arthritis, Systemic Juvenile

Drugs for Rheumatoid Arthritis, Systemic Juvenile (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 28)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Benzocaine Approved, Investigational Phase 3 1994-09-7, 94-09-7 2337
2 tannic acid Approved, Nutraceutical Phase 3
3 Antibodies Phase 3
4 gamma-Globulins Phase 3
5 Immunoglobulins Phase 3
6 Immunoglobulins, Intravenous Phase 3
7 Rho(D) Immune Globulin Phase 3
8 Antibodies, Monoclonal Phase 3
9
Etanercept Approved, Investigational 185243-69-0
10
Methotrexate Approved 1959-05-2, 59-05-2 126941
11
Folic Acid Approved, Nutraceutical, Vet_approved 59-30-3 6037
12
leucovorin Approved, Nutraceutical 58-05-9 143 6006
13 Analgesics
14 Analgesics, Non-Narcotic
15 Anti-Inflammatory Agents
16 Anti-Inflammatory Agents, Non-Steroidal
17 Antimetabolites
18 Antimetabolites, Antineoplastic
19 Antirheumatic Agents
20 Dermatologic Agents
21 Folic Acid Antagonists
22 Gastrointestinal Agents
23 Immunosuppressive Agents
24 Nucleic Acid Synthesis Inhibitors
25 Peripheral Nervous System Agents
26 Vitamin B Complex
27 Folate Nutraceutical
28 Vitamin B9 Nutraceutical

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg) Completed NCT00001768 Phase 3 Intravenous immunoglobulin
2 ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab Completed NCT02296424 Phase 3 ACZ885 150 mg (Canakinumab)
3 A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies Active, not recruiting NCT02334748 Phase 3 canakinumab
4 Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults Completed NCT00534495 Phase 2
5 Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis Completed NCT00078793 Enbrel®

Search NIH Clinical Center for Rheumatoid Arthritis, Systemic Juvenile

Genetic Tests for Rheumatoid Arthritis, Systemic Juvenile

Genetic tests related to Rheumatoid Arthritis, Systemic Juvenile:

# Genetic test Affiliating Genes
1 Rheumatoid Arthritis, Systemic Juvenile 28 IL6 MIF

Anatomical Context for Rheumatoid Arthritis, Systemic Juvenile

MalaCards organs/tissues related to Rheumatoid Arthritis, Systemic Juvenile:

38
Skin, Bone

Publications for Rheumatoid Arthritis, Systemic Juvenile

Articles related to Rheumatoid Arthritis, Systemic Juvenile:

(show top 50) (show all 123)
# Title Authors Year
1
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade. ( 29426067 )
2018
2
The novel use of combined IL-1 and IL-6 inhibition in a patient with severe, aggressive, erosive, systemic-onset juvenile idiopathic arthritis. ( 28293458 )
2017
3
Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review. ( 28499374 )
2017
4
Canakinumab for first line steroid-free treatment in a child with systemic-onset juvenile idiopathic arthritis. ( 28266235 )
2017
5
A Systemic-Onset Juvenile Idiopathic Arthritis Patient with Reduced Anakinra Treatment Admitted with an Attack. ( 28416939 )
2017
6
Systemic-onset juvenile idiopathic arthritis and incomplete Kawasaki disease may belong to a single clinical syndrome within a spectrum of severity. ( 28980895 )
2017
7
Course, Outcome and Complications in Children with Systemic Onset Juvenile Idiopathic Arthritis. ( 28229369 )
2017
8
Extremely elevated IL-18 levels may help distinguish systemic-onset juvenile idiopathic arthritis from other febrile diseases. ( 28225869 )
2017
9
Reasons for inactive disease and flare in systemic onset juvenile idiopathic arthritis patients during tocilizumab treatment. ( 29303703 )
2017
10
Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry. ( 29166924 )
2017
11
Systemic-onset juvenile idiopathic arthritis or incomplete Kawasaki disease: a diagnostic challenge. ( 27782865 )
2016
12
Assessment of vascular function in systemic onset juvenile idiopathic arthritis. ( 27075461 )
2016
13
IL-6 blockers in systemic onset juvenile idiopathic arthritis. ( 26642378 )
2016
14
Systemic onset juvenile idiopathic arthritis and exposure to fine particulate air pollution. ( 27607024 )
2016
15
Should 2016 Criteria for Macrophage Activation Syndrome be applied in children with Kawasaki disease, as well as with systemic-onset juvenile idiopathic arthritis? ( 26965982 )
2016
16
Systemic-onset juvenile idiopathic arthritis. ( 27392503 )
2016
17
Operative stabilization of the remaining mobile segment in ankylosed cervical spine in systemic onset - juvenile idiopathic arthritis: A case report. ( 27458558 )
2016
18
Successful treatment with tocilizumab every 4A weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis. ( 25685108 )
2015
19
Diagnosis of Systemic-Onset Juvenile Idiopathic Arthritis after Treatment for Presumed Kawasaki Disease. ( 25771391 )
2015
20
Myositis as a presenting feature of systemic onset juvenile idiopathic arthritis. ( 25677488 )
2015
21
Bullous Erythema Nodosum Leprosum masquerading as systemic onset juvenile idiopathic arthritis: A case report. ( 26964436 )
2015
22
Successful treatment of macrophage activation syndrome due to systemic onset juvenile idiopathic arthritis with antithymocyte globulin. ( 26210998 )
2015
23
Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome and coronary artery dilatation misdiagnosed as Kawasaki disease. ( 27411422 )
2015
24
Potential Effects of Interleukins on the Pathogenesis of Systemic Onset Juvenile Idiopathic Arthritis. ( 26810447 )
2015
25
A safety evaluation of canakinumab for the treatment of systemic onset juvenile idiopathic arthritis. ( 26568054 )
2015
26
Reversible posterior leukoencephalopathy syndrome secondary to systemic-onset juvenile idiopathic arthritis: A case report and review of the literature. ( 25469247 )
2015
27
Effect of etanercept on refractory systemic-onset juvenile idiopathic arthritis. ( 25754755 )
2015
28
MEFV mutations in egyptian children with systemic-onset juvenile idiopathic arthritis. ( 24862656 )
2014
29
Coronary artery abnormalities in children with systemic-onset juvenile idiopathic arthritis. ( 24793086 )
2014
30
Atopy in children with systemic onset juvenile idiopathic arthritis (SoJIA) is associated with a worse outcome. ( 24611751 )
2014
31
Discrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritis. ( 24786929 )
2014
32
Pathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome" ( 24842480 )
2014
33
Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis. ( 24417800 )
2014
34
A130: Is the CCR5-delta32 Mutation Protective Against Systemic-Onset Juvenile Idiopathic Arthritis? ( 24677884 )
2014
35
Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review. ( 21132551 )
2013
36
Nodular regenerative hyperplasia of the liver as a complication of long-standing systemic-onset juvenile idiopathic arthritis. ( 24315465 )
2013
37
Incomplete Kawasaki disease followed by systemic onset juvenile idiopathic arthritis- the diagnostic dilemma. ( 23054859 )
2013
38
Congestive heart failure: an uncommon presentation of systemic onset juvenile idiopathic arthritis (SOJIA). ( 22161583 )
2013
39
AA amyloidosis associated with systemic-onset juvenile idiopathic arthritis. ( 23664546 )
2013
40
Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes. ( 23915458 )
2013
41
Thalidomide for systemic onset juvenile idiopathic arthritis. ( 23474929 )
2013
42
Systemic-onset juvenile idiopathic arthritis and HLA-B27 juvenile-onset undifferentiated spondyloarthritis in the same patient. ( 23295075 )
2013
43
Fatal myocarditis in a child with systemic onset juvenile idiopathic arthritis during treatment with an interleukin 1 receptor antagonist. ( 22490470 )
2012
44
Anakinra: a safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA). ( 22083619 )
2012
45
ANCA-associated glomerulonephritis in systemic-onset juvenile idiopathic arthritis. ( 22189036 )
2012
46
Leflunomide in systemic onset Juvenile idiopathic arthritis. ( 23024081 )
2012
47
Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India. ( 21221591 )
2012
48
Acute liver failure in young children with systemic-onset juvenile idiopathic arthritis without macrophage activation syndrome: report of two cases. ( 22050445 )
2012
49
Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab. ( 22322589 )
2012
50
Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease. ( 22573189 )
2012

Variations for Rheumatoid Arthritis, Systemic Juvenile

Expression for Rheumatoid Arthritis, Systemic Juvenile

Search GEO for disease gene expression data for Rheumatoid Arthritis, Systemic Juvenile.

Pathways for Rheumatoid Arthritis, Systemic Juvenile

Pathways related to Rheumatoid Arthritis, Systemic Juvenile according to GeneCards Suite gene sharing:

(show all 15)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.53 HLA-DRB1 IL1R1 IL2RB IL6 MIF SERPINA3
2
Show member pathways
12.92 HLA-DRB1 IL1R1 IL2RB IL6
3
Show member pathways
12.39 HLA-DRB1 IL2RB IL6
4
Show member pathways
11.84 IL1R1 IL6 MIF
5
Show member pathways
11.79 HLA-DRB1 IL1R1 IL2RB IL6
6 11.58 IL1R1 IL6 MIF
7
Show member pathways
11.51 IL1R1 IL6
8 11.49 HLA-DRB1 IL6
9
Show member pathways
11.49 HLA-DRB1 IL1R1 IL2RB
10 11.4 IL1R1 IL2RB
11 11.33 HLA-DRB1 IL1R1 IL2RB IL6
12 11.32 HLA-DRB1 IL1R1 IL6
13
Show member pathways
11.28 IL6 MIF
14 11.12 IL1R1 IL6
15 10.88 HLA-DRB1 IL6

GO Terms for Rheumatoid Arthritis, Systemic Juvenile

Cellular components related to Rheumatoid Arthritis, Systemic Juvenile according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 external side of plasma membrane GO:0009897 8.8 HLA-DRB1 IL1R1 IL2RB

Biological processes related to Rheumatoid Arthritis, Systemic Juvenile according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.54 HLA-DRB1 IL1R1 IL6
2 inflammatory response GO:0006954 9.33 IL6 MIF SERPINA3
3 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.32 IL6 MIF
4 positive regulation of peptidyl-serine phosphorylation GO:0033138 9.26 IL6 MIF
5 acute-phase response GO:0006953 8.96 IL6 SERPINA3
6 cytokine-mediated signaling pathway GO:0019221 8.8 IL1R1 IL2RB IL6

Sources for Rheumatoid Arthritis, Systemic Juvenile

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....